Evidence map›Paper›PMID 41338979›Full record

ArticleThe Journal of veterinary medical science2026

Beta-nicotinamide mononucleotide attenuates creatine kinase release in Duchenne muscular dystrophy model rats.

Katsuyuki Nakamura, Masanobu Kanou, Sara Ito, Toshie Jimbo, Karina Kouzaki, Koichi Nakazato, Ryota Nakamjima, Keitaro Yamanouchi, Hiroshi Ueda, Kei Yamana

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of veterinary medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katsuyuki NakamuraDepartment of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan.
Masanobu KanouTeijin Ltd., Tokyo, Japan.
Sara ItoDepartment of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan.
Toshie JimboTeijin Ltd., Tokyo, Japan.
Karina KouzakiGraduate Schools of Health and Sport Science, Nippon Sport Science University, Tokyo, Japan.
Koichi NakazatoGraduate Schools of Health and Sport Science, Nippon Sport Science University, Tokyo, Japan.
Ryota NakamjimaTeijin Ltd., Tokyo, Japan.
Keitaro YamanouchiDepartment of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
Hiroshi UedaDepartment of Chemistry and Biomolecular Science, Faculty of Engineering, Gifu University, Gifu, Japan.
Kei YamanaTeijin Ltd., Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beta-nicotinamide mononucleotide (beta-NMN) is a direct precursor of nicotinamide adenine dinucleotide (NAD

Indexed as

Creatine KinaseMuscular Dystrophy, DuchenneNicotinamide MononucleotideAnimalsDisease Models, AnimalMaleMuscle, SkeletalRatsRats, Sprague-DawleyCreatine KinaseNicotinamide MononucleotideDuchenne muscular dystrophynicotinamide adenine dinucleotide (NAD+)nicotinamide mononucleotide (NMN)rat modelskeletal muscle

Identifiers

PMID41338979
PMCPMC12887104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.